3 Euronext Paris Growth Stocks With Strong Insider Ownership
Reviewed by Simply Wall St
As the French CAC 40 Index experiences modest gains amid hopes for quicker interest rate cuts by the European Central Bank, investors are increasingly focusing on growth stocks with strong insider ownership as a potential avenue for navigating current market conditions. In this context, companies where insiders hold significant stakes can be appealing due to their potential alignment of interests with shareholders and commitment to long-term success.
Top 10 Growth Companies With High Insider Ownership In France
| Name | Insider Ownership | Earnings Growth |
| VusionGroup (ENXTPA:VU) | 13.4% | 81.7% |
| Icape Holding (ENXTPA:ALICA) | 30.2% | 33.9% |
| Arcure (ENXTPA:ALCUR) | 21.4% | 26.6% |
| STIF Société anonyme (ENXTPA:ALSTI) | 16.4% | 22.9% |
| La Française de l'Energie (ENXTPA:FDE) | 19.9% | 31.9% |
| WALLIX GROUP (ENXTPA:ALLIX) | 19.6% | 94.8% |
| Munic (ENXTPA:ALMUN) | 27.1% | 174.1% |
| Adocia (ENXTPA:ADOC) | 11.7% | 64% |
| S.M.A.I.O (ENXTPA:ALSMA) | 17.4% | 103.8% |
| MedinCell (ENXTPA:MEDCL) | 15.8% | 93.9% |
Let's uncover some gems from our specialized screener.
Exclusive Networks (ENXTPA:EXN)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Exclusive Networks SA is a global cybersecurity specialist focused on digital infrastructure, with a market cap of €2.14 billion.
Operations: The company's revenue segments are comprised of €4.19 billion from EMEA, €705 million from the Americas, and €480 million from APAC.
Insider Ownership: 13.1%
Earnings Growth Forecast: 33.5% p.a.
Exclusive Networks, a French cybersecurity firm, is set to be taken private by Clayton, Dubilier & Rice and Permira in a €2.2 billion deal. The company boasts significant insider ownership with 66.7% held by Permira and founder Olivier Breittmayer. Despite recent declines in profit margins and revenue, Exclusive Networks' earnings are forecasted to grow significantly faster than the French market at 33.5% annually, though revenue growth is expected to be moderate at 13.1%.
- Unlock comprehensive insights into our analysis of Exclusive Networks stock in this growth report.
- Our valuation report here indicates Exclusive Networks may be overvalued.
MedinCell (ENXTPA:MEDCL)
Simply Wall St Growth Rating: ★★★★★☆
Overview: MedinCell S.A. is a pharmaceutical company based in France that specializes in developing long-acting injectables across various therapeutic areas, with a market cap of €446.20 million.
Operations: MedinCell generates its revenue primarily from the Pharmaceuticals segment, amounting to €11.95 million.
Insider Ownership: 15.8%
Earnings Growth Forecast: 93.9% p.a.
MedinCell, a French pharmaceutical company, is poised for significant growth with its revenue expected to increase by 46.2% annually, surpassing the French market's average. The firm has been added to the S&P Global BMI Index and recently restructured its governance with new executive appointments. Collaborations like the one with AbbVie could yield up to $1.9 billion in milestones and royalties from innovative therapies using MedinCell's BEPO® technology, enhancing its growth prospects despite negative shareholders' equity concerns.
- Click to explore a detailed breakdown of our findings in MedinCell's earnings growth report.
- Insights from our recent valuation report point to the potential undervaluation of MedinCell shares in the market.
OVH Groupe (ENXTPA:OVH)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions, with a market capitalization of approximately €1.36 billion.
Operations: The company generates revenue from its segments as follows: Public Cloud (€169.01 million), Private Cloud (€589.61 million), and Web cloud & Other (€185.43 million).
Insider Ownership: 10.5%
Earnings Growth Forecast: 101.4% p.a.
OVH Groupe, a French cloud services provider, is trading significantly below its estimated fair value and is expected to achieve profitability within three years, outpacing average market growth. Despite high volatility in its share price recently, the company forecasts earnings growth of over 100% annually. However, revenue growth at 9.7% per year lags behind the ideal threshold but still surpasses the broader French market's rate. Recent presentations at global summits highlight its strategic initiatives.
- Navigate through the intricacies of OVH Groupe with our comprehensive analyst estimates report here.
- Our valuation report unveils the possibility OVH Groupe's shares may be trading at a discount.
Where To Now?
- Dive into all 22 of the Fast Growing Euronext Paris Companies With High Insider Ownership we have identified here.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ENXTPA:MEDCL
MedinCell
A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.
Exceptional growth potential and fair value.
